Search PubMed⌕ Search

Biomedical subjects

K Federlin

Publications and source records attributed to K Federlin.

At least 253 records · Page 14Linked to original sources
PubMed1985

[ELISA detection of protamine antibodies].

Protamine is frequently used as an adjuvant in insulin preparations. As alien protein protamine is immunogenic. We developed an ELISA for detection of protamine antibodies. As a strongly basic molecule protamine shows remarkable reactivity. Resulting methodical difficulties with regard to the assay are discussed. The course of antibody titres to protamine after immunization is shown in rabbits, goats, sheep and guinea pigs with positive results in all species. In humans protamine antibodies were detectable in 4% of 150 patients treated with protamine insulins.

Animals↗
PubMed1985

[Diabetes mellitus and immunology--a manifold interrelation].

The purpose of this article is to describe the manifold interrelations between diabetes mellitus and immunology. The survey starts with immune defects caused by insulin deficiency and expressed by reduced phagocytic functions of macrophages and decreased responsiveness of lymphocytes to mitogens. The following topic deals with immunologic side effects of insulin therapy due to species differences and impurities in former insulin preparations. Also in human insulin therapy small amounts of IgE and IgG antibodies are observed, although clinically insulin immunology in the future will be of minor importance for diabetic patients. Autoimmunity to islet antigens plays a major role in diabetes research. Some characteristics of islet cell antibodies are described and their impact on the pathogenesis of type I diabetes is discussed. Finally experimental islet transplantation and the attempts of immunoalteration of allogeneic islets are mentioned.

Desensitization, Immunologic↗
PubMed1984

[Combination therapy with insulin and sulfonylurea in secondary failure of sulfonylurea therapy].

Among 16 type II diabetics who were secondary failures on sulphonylurea treatment alone, eight (group A) were changed to a combined regimen of insulin and sulphonylurea (glibenclamide), the other eight (group B) received insulin alone. Patients in group A were on the combined schedule for ten days, followed by ten days of insulin alone, followed by six months of combined treatment. In the first ten days those on combined treatment in group A required on average 30% less insulin that those of group B, with a comparable metabolic state, while insulin requirements significantly rose after ten days on insulin alone. After renewed combined treatment the insulin dose could once again be reduced, but after eight weeks there was a rise in the insulin requirement, as for group B patients. During the further observation period of three months there were no significant differences in the insulin requirement between the two groups. Combination treatment with sulphonylurea and insulin in secondary failures thus, in the short term, reduces insulin requirement; but in the long term it is not significantly different from insulin treatment alone.

Aged↗
PubMed1984

Virus infection islet cell antibodies and islet cell function in type I diabetes mellitus.

The detection of islet cell antibodies has led to an increasing interest in autoimmune mechanisms in Type I diabetes mellitus. Other phenomena, such as insulitis in juvenile diabetics and in experimental animals, cellular immune reactions and concommitant antibodies against other endocrine organs, antinuclear antibodies and circulating immune complexes have supported such speculations. HLA-association and viral-infections could be predisposing and inducing factors. However, with one exception, the occurrence of ICA in a group of mumps infected children did not result in the development of diabetes mellitus over 3-4 years, nor could it be correlated with HLA-pattern. The islet cell antibodies block glucose stimulated insulin secretion in vitro without complement, while Type I diabetic sera with complement are beta cell cytotoxic irrespective of their ICA concentration. It is still not clear whether these mechanisms play any role in vivo. Therapeutic intervention before the clinical manifestation of the disease is as yet not possible due to the lack of markers indicating a subclinical autoimmune process.

Adolescent↗
PubMed1984

Mumps, mumps vaccination, islet cell antibodies and the first manifestation of diabetes mellitus type I.

To connect mumps and diabetes mellitus in children is an old problem in medical literature. The typical occurrence of ICA at the onset of diabetes in children, as well as the incidence of ICA approximately 3 weeks after mumps infection support the hypothesis of a direct relationship between virus infection and diabetes. But the mumps infection alone is not the key factor. Mumps vaccination may not provide protection against diabetes mellitus, it may even provoke it. (Genetic determination, expressed by the HLA-phenotype in all the patients reported, does not allow a differentiation.)

Adolescent↗
PubMed1983

[Immunohistologic determination of a tumor marker (CEA) in diseases of the gastrointestinal tract].

CEA levels in serum are not reliable markers of tumors. In this paper a method for determination of this antigen for tissue sections is given. Histology, immunohistology and serum levels of CEA were compared. Tissue sections were obtained by surgical and endoscopic techniques. In several cases there was a discrepancy between serological and morphological results. Based on recent investigations elevated CEA levels might be only useful in reflecting a relapse of carcinoma of the colon. Immunohistological determinations were done by IFT and PAP-method. The results of both assay systems were comparable. CEA could be also detected in benign neoplasiogenic tissue, i.e. in tubular type of adenomatose polyps and in ulcerative colitis. Both diseases are known to become malignant at an high degree. By contrast no CEA could be detected in hyperplasiogenic polyps. Detection of CEA in malignant tissue might be useful for final classification of tumors. Occurrence of CEA in non malignant tissue should give rise to control in short regular intervals. Prospective studies might show the reliability of the CEA-bearing cells of non malignant tissue.

Adolescent↗
PubMed1983

[Autoimmune phenomena in diabetes mellitus. On the pathogenetic and diagnostic significance].

The detection of islet cell antibodies lead to an increasing interest in autoimmune mechanisms in Typ I diabetes mellitus. Other phenomena such as insulitis in juvenile diabetics and in experimental animals, cellular immune reactions and concomitant antibodies against other endocrine organs, antinuclear antibodies and circulating immune complexes supported these suggestions. HLA-association and viral infections could be predisposing and inducing factors, although there are no clear correlations to any viral infection in a larger number of patients so far. For clinical and therapeutic purposes there are not enough sufficient criteria to demonstrate a pathologic autoimmune process in patients before developing diabetes. Up to now there is no realistic possibility and justification for starting an early immunosuppressive therapy.

Animals↗
PubMed1983

[Immunomodulation with symptomatically effective antirheumatic agents].

As antigen-presenting and/or monokine-secreting cells, macrophages play a major role in immunoregulation. Proteases of macrophage origin (cathepsin G, elestase , thrypsin and pronase) act on cell surfaces of different cell lines, inducing cell activation, e.g. of B-lymphocytes. T-lymphocytes might be stimulated by the activating factor LAF. Other macrophage products (CSF, FIM ) control monocyte production in bone marrow. While lymphocytes are the target cell lines for classical immunosuppressive agents, mononuclear phagocytes are kept for the major cell population affected by antiinflammatory drugs. The presented study outlines the significance of the mononuclear-phagocyte-system in antiinflammatory drug research. The inhibiting potency of antiinflammatory drugs on the monocyte-macrophage cell line as an additional immunoregulatory principle should be discussed.

Animals↗